U.S. Sucralfate Market Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Stomach Ulcers
Sucralfate is a drug that acts as a protective coating for stomach ulcers, duodenal ulcers and gastroesophageal reflux disease (GERD). It is available in oral suspension form as well as tablet form. Sucralfate forms a chemical bond with proteins on the lining of ulcers to shield them from stomach acid and digestive juices. This promotes healing of ulcers by allowing the body's natural repair processes to close the ulcers.
The U.S. sucralfate market is estimated to be valued at US$ 60.8 Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Increasing prevalence of stomach ulcers in the U.S. is expected to drive the sucralfate market growth over the forecast period. According to the American College of Gastroenterology, around 4 million people in the U.S. have been diagnosed with stomach ulcers annually. Risk factors such as heavy alcohol use, smoking, diet, stress and certain medications can lead to development of ulcers.
Additionally, increasing adoption of sucralfate as a first line of defense in ulcer treatment is also expected to support market growth between 2023 and 2030. Sucralfate provides quick relief from ulcer symptoms and aids rapid healing. Its advantages over other drugs include lower incidence of side effects and less drug interactions.
Explorer more information on this topic, Please visit @ https://samruddhicmi123.blogspot.com/2023/12/the-us-sucralfate-market-is-estimated.html
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian